CASC3 Antikörper (N-Term)
-
- Target Alle CASC3 Antikörper anzeigen
- CASC3 (Cancer Susceptibility Candidate 3 (CASC3))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CASC3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- CASC3 antibody was raised against the N terminal of CASC3
- Aufreinigung
- Affinity purified
- Immunogen
- CASC3 antibody was raised using the N terminal of CASC3 corresponding to a region with amino acids MADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPS
- Top Product
- Discover our top product CASC3 Primärantikörper
-
anti-Cancer Susceptibility Candidate 3 (CASC3) antibody
CASC3 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 206-236) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB10332 unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 159-188) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15327 unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 604-703) antibodyCASC3 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (pTyr181) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 159-188) antibodyCASC3 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (N-Term) antibodyCASC3 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schwein, Meerschweinchen, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (C-Term) antibodyCASC3 Reaktivität: Human, Maus WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (AA 202-233), (C-Term) antibodyCASC3 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cancer Susceptibility Candidate 3 (CASC3) (Tyr181) antibodyCASC3 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
CASC3 Blocking Peptide, catalog no. 33R-5626, is also available for use as a blocking control in assays to test for specificity of this CASC3 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CASC3 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- CASC3 (Cancer Susceptibility Candidate 3 (CASC3))
- Andere Bezeichnung
- CASC3 (CASC3 Produkte)
- Synonyme
- BTZ antikoerper, MLN51 antikoerper, Btz antikoerper, Mln51 antikoerper, CASC3 antikoerper, btz antikoerper, mln51 antikoerper, StMLN51 antikoerper, barentsz antikoerper, XlMLN51 antikoerper, cancer susceptibility 3 antikoerper, cancer susceptibility candidate 3 antikoerper, protein CASC3 antikoerper, cancer susceptibility 3 S homeolog antikoerper, CASC3 antikoerper, Casc3 antikoerper, casc3 antikoerper, casc3.S antikoerper
- Hintergrund
- The product of this gene is a core component of the exon junction complex (EJC), a protein complex that is deposited on spliced mRNAs at exon-exon junctions and functions in nonsense-mediated mRNA decay (NMD).
- Molekulargewicht
- 76 kDa (MW of target protein)
-
